SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

$FUUU is a Solana-based memecoin that was launched on http://Pump.fun in March 2024. The project is themed around the Rage Guy character, a figure that originated in the rage comic era of the late 2000s and became widely recognized across internet culture. Following the launch, the original developer discontinued involvement with the token. At that point, the CTO team assumed responsibility for coordinating ongoing community efforts around the project.  The stated purpose of $FUUU is cultural rather than financial. It is designed as a “culture coin” that highlights Rage Guy as a symbolic and relatable figure. The character’s expression of frustration, commonly represented by the text “FFFFUUUU,” reflects emotions that are often tied to both cryptocurrency markets and everyday experiences. By building a token around this meme, the project aims to preserve a recognizable piece of internet history within a blockchain context.  Unlike projects that emphasize detailed roadmaps, technical milestones, or defined utility, $FUUU positions itself as a lighthearted and entertainment-driven token. There are no team allocations, no taxes, and no embedded promises of profit or financial return. The coin is intended solely for cultural engagement, community participation, and meme creation. Holders and community members are encouraged to contribute through content, discussion, and the continued use of Rage Guy imagery, but there are no obligations or formal expectations tied to the token.  The CTO team provides organizational support, and back end support such as hiring an artist and creatin websites, the community drives activity associated with the project. This includes creating and sharing memes, maintaining discussion channels, and ensuring the Rage Guy character remains present in contemporary internet culture. The project does not claim utility beyond its role as a culture coin, and its sustainability depends entirely on voluntary participation and ongoing community interest.  From a transparency standpoint, the on-chain parameters of the token are publicly visible. These include the mint authority status, freeze authority, liquidity details (whether burned or locked), and circulating supply information. Any locked or burn addresses are disclosed for the purpose of supporting accurate supply tracking on external platforms.  Rage Guy ($FUUU) should not be viewed as an investment. The token has no intrinsic value and provides no rights, revenue, or guarantees to holders. As with all cryptoassets, trading is highly risky, and participants are advised to conduct their own research and fully understand the risks involved. The project’s focus remains cultural preservation and community expression rather than financial

FUUUUUUUUUUUUUU

Investors are fueling intense volatility in FUUU as the community leans into its role as a high-risk, speculative meme asset that embodies a collective protest against current market conditions. While some participants dismiss the project as a potential rug pull or scam, others are actively accumulating positions in hopes of capturing explosive upward price momentum.

Gorilla Technology Group, Inc. engages in the provision of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology security solutions and services in Asia Pacific. It operates through the following segments: Video IoT, Security Convergence, and Other. The company was founded by Spincer Koh in May 2001 and is headquartered in London, the United Kingdom.

Gorilla Technology Group Inc

Gorilla Technology Group is currently trending following a binding agreement to deploy high-performance GPU infrastructure for Yotta Data Services in India, a deal projected to generate significant multi-year revenue. While bullish investors view the contract as institutional validation and a catalyst for long-term growth, the community remains actively divided as skeptics point to historical price declines, ongoing concerns over share dilution, and the need for greater transparency regarding operational execution.

Solphin

The community is rallying around SOLPHIN as a potential breakout in the aquatic-themed meme coin sector, fueled by speculation that an exit by early large-scale holders will clear the path for a rally. Traders are actively debating the token's speculative potential while navigating high volatility and calls to increase social media visibility.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQ is experiencing intense market volatility and high trading volume following an earnings report that exceeded top-line expectations, fueling significant retail momentum and aggressive short-squeeze activity. While bullish investors point to strategic acquisitions and defense-sector contracts as evidence of long-term commercial scalability, the community remains deeply divided, with many actively debating the stock's valuation, heavy short interest, and the sustainability of its growth-by-acquisition strategy.

Pyth Network is a decentralised oracle network designed to provide real-time financial market data to decentralised applications (dApps) across multiple blockchains. It allows developer to secure smart contracts with reliable, low-latency market data from institutional sources, and build apps with high-fidelity oracle feeds designed for mission-critical systems.

Pyth Network

Pyth Network is trending as investors highlight its role as essential DeFi infrastructure, particularly following its partnership with the U.S. Department of Commerce to provide official macroeconomic data on-chain. Community sentiment is focused on the project's institutional-grade data feeds, recent revenue-sharing through token buybacks, and its growing importance within the Real World Asset (RWA) sector.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is currently experiencing significant downward price pressure and low trading volume, as investors wait for tangible evidence of Yartemlea's sales ramp following its FDA approval. The community is actively debating the impact of institutional shorting and option pinning while expressing strong conviction in the stock's long-term valuation based on the Novo Nordisk partnership and upcoming European regulatory milestones.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending as investors weigh its unique body-composition-focused obesity candidate, WVE-007, against the broader incretin market, with the community actively debating the durability and clinical efficacy of its muscle-sparing RNA interference platform following recent trial updates.

Fiserv, Inc. engages in the provision of financial services technology. It operates through the Merchant and Financial segments. The Merchant segment offers commerce-enabling products and services including merchant acquiring and digital commerce and mobile payment services, and security and fraud protection, stored-value, and pay-by-bank solutions to companies of all sizes. The Financial segment provides products and services such as processing of customer loan and deposit accounts, digital payments, and card transactions to financial institutions and corporate and public sector clients. The company was founded by Leslie M. Muma and George D. Dalton on July 31, 1984 and is headquartered in Milwaukee, WI.

Fiserv, Inc.

Fiserv is trending as investors react to a fiscal report that met guidance but highlighted slowing growth and margin pressure, fueling intense community debate over whether the stock is a deep-value opportunity or a long-term value trap. The conversation is currently dominated by conflicting views on the effectiveness of the new leadership's turnaround strategy, with many shareholders frustrated by consistent underperformance despite the company's historically low valuation and essential role in payment infrastructure.

FS KKR Capital Corp. is an externally managed, non-diversified, and closed-end management investment company that has been elected to be regulated as a business development company. Its portfolio includes FS Investments and KKR Credit. The company was founded by Michael Craig Forman on December 21, 2007 and is headquartered in Philadelphia, PA.

FS KKR Capital Corp

FS KKR Capital is facing significant selling pressure as investors grapple with a substantial distribution cut and concerns over the company's software-heavy portfolio exposure, leading to discussions about potential further downside to NAV. While some bargain hunters are attempting to build positions at multi-year lows, the prevailing sentiment remains bearish with traders actively buying put options to hedge against the ongoing credit cycle uncertainty.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Two Interactive is experiencing intense volatility as investors debate whether the recent GTA VI release date confirmation and robust bookings provide a solid long-term foundation or if the stock is being manipulated by institutional sell-offs. The community remains deeply divided, with many long-term holders treating dips as buying opportunities while short-term traders express frustration over perceived insider trading and the constant threat of further project delays.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Selling: Entrada Therapeutics (NASDAQ:TRDA) COO Sells 3,116 Shares of Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 3,116 shares of the firm's stock in a transaction that occurred on Monday, March 9th. The stock was sold at an...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 5,089 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 5,089 shares of the firm's stock in a transaction that occurred on Monday, March 9th. The shares were sold at...

Entrada Therapeutics (NASDAQ:TRDA) COO Sells $155,216.70 in Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) COO Nathan Dowden sold 11,894 shares of the stock in a transaction on Tuesday, March 10th. The stock was sold at an average price of $13.05...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 11,388 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 11,388 shares of the company's stock in a transaction on Tuesday, March 10th. The stock was sold at an average...

Entrada Therapeutics (NASDAQ:TRDA) Hits New 1-Year High - Time to Buy?

Entrada Therapeutics (NASDAQ:TRDA) Reaches New 12-Month High - Still a Buy...

Entrada Therapeutics (NASDAQ:TRDA) CFO Kory James Wentworth Sells 7,988 Shares

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 7,988 shares of the business's stock in a transaction on Wednesday, March 4th. The stock was sold at an...

Kory James Wentworth Sells 7,988 Shares of Entrada Therapeutics (NASDAQ:TRDA) Stock

Entrada Therapeutics, Inc. (NASDAQ:TRDA - Get Free Report) CFO Kory James Wentworth sold 7,988 shares of the business's stock in a transaction on Wednesday, March 4th. The shares were sold at an...

Royce & Associates LP Raises Stock Position in Entrada Therapeutics, Inc. $TRDA

Royce & Associates LP grew its stake in Entrada Therapeutics, Inc. (NASDAQ:TRDA - Free Report) by 54.8% in the 3rd quarter, according to its most recent filing with the Securities and Exchange...

Entrada Therapeutics (NASDAQ:TRDA) Stock Rating Upgraded by Wall Street Zen

Wall Street Zen raised Entrada Therapeutics from a "sell" rating to a "hold" rating in a research note on Saturday...

Entrada Therapeutics (NASDAQ:TRDA) Posts Earnings Results, Beats Estimates By $0.38 EPS

Entrada Therapeutics (NASDAQ:TRDA - Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.94) earnings per share (EPS) for the quarter, topping the consensus...

Entrada Therapeutics, Inc. is a clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The company’s Endosomal Escape Vehicle (EEV) therapeutics are designed to enable the efficient intracellular delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Through this proprietary, versatile and modular approach, Entrada is advancing a robust development portfolio of RNA- and protein-based programs for the potential treatment of neuromuscular and ocular diseases, among others. The company’s oligonucleotide programs are in development for the potential treatment of people living with Duchenne who are exon 44, 45, 50 and 51 skipping amenable. Entrada has partnered to develop a clinical-stage program, VX-670, for myotonic dystrophy type 1. Entrada Therapeutics was founded by Dehua Pei in 2016 and is headquartered in Boston, MA.

Entrada Therapeutics Inc

Peloswing

JFDI

ACInvestorBlog

GPaisa

A pillar of the Stocktwits ecosystem. This award recognizes the member who fosters connection, shares invaluable insights, and elevates the daily discussion to empower their fellow traders, on-platform.

TRDA
Entrada Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest TRDA News

TRDAEntrada Therapeutics Inc